
Alert: Rating Downgrade (4/1/25)-Corcept Therapeutics Inc (NASDAQ: CORT).
Stock Rating Downgrade In the last week the Value Trend Rating for Corcept Therapeutics Inc (NASDAQ: CORT) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Corcept Therapeutics Inc […]